These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26584542)

  • 1. Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.
    Cho SJ; Kim SY; Jeong HC; Cheong H; Kim D; Park SJ; Choi JJ; Kim H; Chung HM; Moon SH; Cha HJ
    Stem Cell Reports; 2015 Dec; 5(6):1067-1080. PubMed ID: 26584542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies.
    Chour T; Tian L; Lau E; Thomas D; Itzhaki I; Malak O; Zhang JZ; Qin X; Wardak M; Liu Y; Chandy M; Black KE; Lam MP; Neofytou E; Wu JC
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation.
    Choi SW; Shin TH; Uddin MH; Shin JH; Kang TW; Lee BC; Kim HS; Seo Y; Shams S; Jung YK; Kang KS
    Oncotarget; 2016 Jan; 7(3):2684-95. PubMed ID: 26646796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of pluripotent stem cell cytotoxic small molecules.
    Richards M; Phoon CW; Goh GT; Seng EK; Guo XM; Tan CM; Chan WK; Lee JM
    PLoS One; 2014; 9(3):e85039. PubMed ID: 24647085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells.
    Choi KA; Park HK; Hwang I; Jeong H; Park HS; Jang AY; Namkung Y; Hyun D; Lee S; Yoo BM; Kwon HJ; Seol KC; Kim JO; Hong S
    Stem Cells; 2020 Apr; 38(4):516-529. PubMed ID: 31778275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
    Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation.
    Park J; Lee DG; Lee NG; Kwon MG; Son YS; Son MY; Bae KH; Lee J; Park JG; Lee NK; Min JK
    BMB Rep; 2022 Mar; 55(3):142-147. PubMed ID: 34674794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.
    Lian Q; Zhang Y; Zhang J; Zhang HK; Wu X; Zhang Y; Lam FF; Kang S; Xia JC; Lai WH; Au KW; Chow YY; Siu CW; Lee CN; Tse HF
    Circulation; 2010 Mar; 121(9):1113-23. PubMed ID: 20176987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible Light.
    Cho SJ; Kim SY; Park SJ; Song N; Kwon HY; Kang NY; Moon SH; Chang YT; Cha HJ
    ACS Cent Sci; 2016 Sep; 2(9):604-607. PubMed ID: 27725957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.
    Smith AJ; Nelson NG; Oommen S; Hartjes KA; Folmes CD; Terzic A; Nelson TJ
    Stem Cells Transl Med; 2012 Oct; 1(10):709-18. PubMed ID: 23197662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical approaches to induce selective cell death of pluripotent stem cells.
    Jeong HC; Cho SJ; Lee MO; Cha HJ
    Cell Mol Life Sci; 2017 Jul; 74(14):2601-2611. PubMed ID: 28246701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155.
    Kang SJ; Park YI; Hwang SR; Yi H; Tham N; Ku HO; Song JY; Kang HG
    Stem Cell Res Ther; 2017 Apr; 8(1):78. PubMed ID: 28412976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells.
    International Stem Cell Initiative
    Nat Commun; 2018 May; 9(1):1925. PubMed ID: 29765017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.
    Yang Y; Adachi K; Sheridan MA; Alexenko AP; Schust DJ; Schulz LC; Ezashi T; Roberts RM
    Proc Natl Acad Sci U S A; 2015 May; 112(18):E2337-46. PubMed ID: 25870291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis.
    Kim A; Lee SY; Seo CS; Chung SK
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The teratoma assay: an in vivo assessment of pluripotency.
    Wesselschmidt RL
    Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
    Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
    J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A system for treating ischemic disease using human embryonic stem cell-derived endothelial cells without direct incorporation.
    Moon SH; Kim JS; Park SJ; Lee HJ; Do JT; Chung HM
    Biomaterials; 2011 Sep; 32(27):6445-55. PubMed ID: 21658762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants.
    Bieberich E; Silva J; Wang G; Krishnamurthy K; Condie BG
    J Cell Biol; 2004 Nov; 167(4):723-34. PubMed ID: 15545317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective eradication of pluripotent stem cells by inhibiting DHODH activity.
    Kondo T
    Stem Cells; 2021 Jan; 39(1):33-42. PubMed ID: 33038285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.